Looking back: a review of policy implications for exercise oncology

J Natl Cancer Inst Monogr. 2023 May 4;2023(61):140-148. doi: 10.1093/jncimonographs/lgad002.

Abstract

The evidence to support the benefits of exercise for people living with and beyond cancer is robust. Still, exercise oncology interventions in the United States are only eligible for coverage by third-party payers within the restrictions of cancer rehabilitation settings. Without expanded coverage, access will remain highly inequitable, tending toward the most well-resourced. This article describes the pathway to third-party coverage for 3 programs that address a chronic disease and utilize exercise professionals: the Diabetes Prevention Program, Supervised Exercise Training for Peripheral Artery Disease, and Cancer Rehabilitation. Lessons learned will be applied toward expanding third-party coverage for exercise oncology programming.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Exercise
  • Exercise Therapy
  • Humans
  • Medical Oncology
  • Neoplasms* / diagnosis
  • Neoplasms* / epidemiology
  • Neoplasms* / therapy
  • Peripheral Arterial Disease*
  • United States / epidemiology